Sunshine Biopharma (SBFM) FCF Margin (2015 - 2026)
Sunshine Biopharma (SBFM) posted FCF Margin of 25.68% for Q1 2026, down 36.39% on a QoQ basis from 18.83% in Q4 2025, and down 655.0% year-over-year from 4.63% in Q1 2025.
Sunshine Biopharma (SBFM) FCF Margin (2015 - 2026) Analysis & Trends
Sunshine Biopharma's FCF Margin history runs 10 years deep, the most recent figure standing at 25.68% for Q1 2026.
- Quarterly FCF Margin fell 655.0% year-over-year to 25.68% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 16.57% (up 1831.0% YoY) and the FY2025 annual result came in at 15.16%, up 2550.0% from the prior year.
- FCF Margin was 25.68% for Q1 2026 at Sunshine Biopharma, down from 18.83% in the prior quarter.
- Across five years, FCF Margin topped out at 7.81% in Q3 2025 and bottomed at 1063.4% in Q1 2022.
- A 5-year average of 161.49% and a median of 36.56% in 2024 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin tumbled 32109 bps — and 2023, when it jumped 102560 bps.
- Sunshine Biopharma's FCF Margin stood at 61.95% in 2022, then soared by 52 bps to 30.04% in 2023, then fell by 22 bps to 36.56% in 2024, then jumped by 48 bps to 18.83% in 2025, then tumbled by 36 bps to 25.68% in 2026.
- Business Quant data shows SBFM's FCF Margin at 25.68% in Q1 2026, 18.83% in Q4 2025, and 7.81% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 91.98 Bn | 90.11 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | -5.22% |
| 3 | Zoetis | 32.99 Bn | 31.05 Bn | 1.62 Bn | 12.86% |
| 4 | Takeda Pharmaceutical | 27.75 Bn | 23.69 Bn | 4.39 Bn | -5.35% |
| 5 | United Therapeutics | 23.03 Bn | 20.87 Bn | 648.10 Mn | 46.54% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.51 Bn | 18.70 Bn | 1.16 Bn | 9.93% |
| 8 | Neurocrine Biosciences | 18.10 Bn | 16.78 Bn | 800.70 Mn | 17.73% |
| 9 | Elanco Animal Health | 12.77 Bn | 12.34 Bn | 785.00 Mn | -2.77% |
| 10 | Sunshine Biopharma | 696,643.46 | -6.22 Mn | 2.18 Mn | -25.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.68% |
| Dec 31, 2025 | -18.83% |
| Sep 30, 2025 | -7.81% |
| Jun 30, 2025 | -15.43% |
| Mar 31, 2025 | -19.13% |
| Dec 31, 2024 | -36.56% |
| Sep 30, 2024 | -22.21% |
| Jun 30, 2024 | -59.68% |
| Mar 31, 2024 | -43.07% |
| Dec 31, 2023 | -30.04% |
| Sep 30, 2023 | -7.84% |
| Jun 30, 2023 | -67.94% |
| Mar 31, 2023 | -37.80% |
| Dec 31, 2022 | -61.95% |
| Sep 30, 2022 | -846.14% |
| Jun 30, 2022 | -381.75% |
| Mar 31, 2022 | -1,063.40% |
| Dec 31, 2021 | -366.68% |
| Sep 30, 2021 | -1,192.65% |
| Jun 30, 2021 | -1,170.43% |